We deliver.
Natural delivery to unlock the full potential of cell and gene therapies
Our delivery platform
Our delivery platform
Imagine a world where we conquer cancer and genetic diseases.
At NTrans, we solve key challenges in cell and gene therapy:
Delivering life-changing therapies to the right cells and tissues.
We leverage nature’s own mechanisms for cellular uptake to ensure efficient and safe therapeutic delivery.
Welcome to the next frontier of medicine.
Quick facts
Non-viral delivery
Natural uptake mechanism
High gene editing efficiency
High cell viability
Excellent intrinsic safety
Simple implementation
Low manufacturing costs
High scalability
Mission statement
The mission of NTrans Technologies is to become the leading non-viral delivery platform in cell and gene therapy.
Opportunities
We have developed a game-changing, modular delivery platform, designed for easy integration with the therapeutic development processes of our strategic partners. This platform sets a new standard in gene therapy, accelerating the path to patient care.
CAR-T
Our technology revolutionizes CAR-T cell therapy, allowing precise editing and integration of chimeric antigen receptors (CARs). This enhances the accuracy of cancer-targeting immune responses.
CRISPR/Cas9
We have mastered the delivery of CRISPR-Cas9 (RNP complexes) into cells, paving the way for precise genome editing. Our technology facilitates a multitude of research and therapeutic possibilities.
Base editors
Our system delivers Base editors into cells, targeting specific DNA changes without causing double-strand breaks. This approach significantly enhances the safety and reliability of gene editing.
Prime editors
Our technology excels at introducing Prime editors into cells. This enables precise and controlled DNA sequence modifications with accuracy and minimal off-target effects.
News
Dutch Life Science Conference
NTrans joins the Dutch Life Science Conference 7 December 2023, Corpus Leiden.
Read More
